Event Type: Seminar
- Location Name:
- Omni Parker House, 60 School Street, Boston MA 02108
- Start Date/Time:
- 17 September 2014, 1:00 PM EDT
- End Date/Time:
- 19 September 2014, 5:00 PM EDT
ACI’s FDA Boot Camp has been designed by leading regulatory attorneys to give professionals that work in conjunction with the pharmaceutical, biologics, and medical devices industries — such as products or patent litigators, as well as patent prosecutors, industry in-house counsel, and life sciences investment and securities experts — a strong working knowledge of core FDA competencies.
A distinguished faculty of top FDA regulatory experts — a “Who’s Who of the FDA Bar” — will share their knowledge and give you critical insights on:
- The organization, jurisdiction, functions, and operations of the FDA
- The essentials of the approval process for drugs, biologics, and devices, including:
- NDAs
- INDs
- BLAs
- OTC Approval
- 510(k) submissions
- PMA process
- Clinical trials for drugs and biologics and the clearance process for devices
- The classification of devices and the concept of “risk-based” classification
- The role of the Hatch-Waxman Act in the patenting of drugs and biologics
- Labeling in the drug and biologics approval process
- cGMPs and other manufacturing concerns relative to products liability
- Proactive adverse events monitoring and signal detection
- Recalls, product withdrawals, and FDA oversight authority
Join Reed Smith Counsel, James Beck, for his presentation entitled "Preemption Fundamentals."
Download the PDF for additional information.